Researcher.Life Logo

Strahlentherapie und Onkologie : Impact Factor & More

eISSN: 1439-099XpISSN: 0179-7158

Key Metrics

CiteScore
5.7
Impact Factor
< 5
SJR
Q2Oncology
SNIP
1.15
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Strahlentherapie und Onkologie

Strahlentherapie und Onkologie Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher SPRINGER HEIDELBERG
Language Multi-Language
Frequency Monthly
General Details
LanguageMulti-Language
FrequencyMonthly
Publication Start Year1986
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Strahlentherapie und Onkologie ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Strahlentherapie und Onkologie

From fractionation to financials: economic and clinical implications of hypofractionation in German outpatient radiotherapy practice.
  • 26 Nov 2025
  • Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
Radiation protection procedures in the context of the new Medical Research Act: what has changed, what has not? Ajoint overview by the German Society for Radiation Oncology (DEGRO) and the Federal Office for Radiation Protection (BfS)
  • 20 Nov 2025
  • Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
Correction to: From protocol to practice: long-Term outcomes of single-Fraction stereotactic body radiotherapy for primary non-Small cell lung cancer.
  • 19 Nov 2025
  • Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
Perioperative immune checkpoint inhibition with pembrolizumab in combination with adjuvant therapy improves event-free survival for operable locally advanced head and neck tumors
  • 12 Nov 2025
  • Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
Role of primary chemoradiotherapy in the management of advanced stage vulvar cancer : Experience of alarge cancer center.
  • 10 Nov 2025
  • Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
Research with cancer registry data in radiation oncology-current possibilities and perspectives : Anarrative review.
  • 10 Nov 2025
  • Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
From fractionation to financials: economic and clinical implications of hypofractionation in German outpatient radiotherapy practice.
  • 26 Nov 2025
  • Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
Radiation protection procedures in the context of the new Medical Research Act: what has changed, what has not? Ajoint overview by the German Society for Radiation Oncology (DEGRO) and the Federal Office for Radiation Protection (BfS)
  • 20 Nov 2025
  • Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
Correction to: From protocol to practice: long-Term outcomes of single-Fraction stereotactic body radiotherapy for primary non-Small cell lung cancer.
  • 19 Nov 2025
  • Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
Perioperative immune checkpoint inhibition with pembrolizumab in combination with adjuvant therapy improves event-free survival for operable locally advanced head and neck tumors
  • 12 Nov 2025
  • Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
Role of primary chemoradiotherapy in the management of advanced stage vulvar cancer : Experience of alarge cancer center.
  • 10 Nov 2025
  • Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
Research with cancer registry data in radiation oncology-current possibilities and perspectives : Anarrative review.
  • 10 Nov 2025
  • Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]

FAQs on Strahlentherapie und Onkologie